Red Nucleus

Using our Learning & Development toolkits, your Global Marketing and Global Medical Affairs teams can deploy assets to regional colleagues to: ? Ensure your approved message is compliantly discussed with your targeted customers ? Create a scalable solution that can be used over time as launch plans progress globally ? Generate excitement and buy-in around your program materials Please contact the Red Nucleus Learning & Development team to hear about how our proprietary solutions for Worldwide Team Members can ensure a successful handoff to your colleagues. Create impactful interactions with your targeted healthcare providers with confidence. ???? #medaffairs?#MedicalCommunications https://lnkd.in/gvzAMZf5

The Red Nucleus team is gearing up to attend MAPS Americas 2025 in New Orleans from March 23-26! We're ready to connect with industry leaders and discuss the latest trends in Medical Affairs. Join us to explore innovative solutions and strategies that are shaping the future of healthcare. Reach out to us to schedule a meeting and discover how Red Nucleus can support your Medical Affairs journey. ?????? #MAPS2025 #MedicalAffairs #RedNucleus

The Red Nucleus Team – Ian Kelly, Dalia El-Sherif, and Willem Heydendael – will be attending Pharma 2025 on March 18-19! We're looking forward to discussing the latest innovations and exploring potential collaboration opportunities. Planning to attend? We'd love to connect! Drop a comment below or send us a message to schedule a meeting during the event. ?????? #RedNucleus #Pharma2025

We're excited to announce that our team will be attending the 2025 MDA Clinical & Scientific Conference in Dallas, Texas, from March 16-19! Let's work together to drive transformative care and treatments for neuromuscular diseases! Reach out to us to schedule a meeting and discover how we can support your journey in neuromuscular disease research and care. ?????? #MDA2025 #NeuromuscularDisease #InnovationInHealthcare

The Red Nucleus team has landed at the World Evidence, Pricing, and Access Congress! We're excited to connect with industry leaders, discuss the latest trends in market access, pricing strategies, and explore innovative solutions for the pharmaceutical industry. Visit us at booth 47 to learn how we're helping companies navigate the complexities of today's healthcare landscape. #WorldEPA #MarketAccess #Pricing #RedNucleus

Welcome COEUS! We're expanding our market access capabilities with the acquisition of COEUS, a leading healthcare firm specializing in market access strategic consulting and creative communications Mike Menta, CEO, notes: "Together, we've created the industry's leading market access business, helping bring critical therapies to patients who need them most." https://hubs.li/Q035dQ5y0 #LifeSciences #HealthcareInnovation #MarketAccess

The day has arrived! Red Nucleus is thrilled to be part of the DIA RSIDM Forum 2025! We're ready to dive into three days of knowledge sharing, networking, and collaboration with industry experts and regulators from around the world. Stop by our booth to chat about how Red Nucleus can support your regulatory strategies and operations. Let's make the most of #RSIDM2025 together! ?? ?? ?? #RegulatoryAffairs #PharmaTech #RedNucleus

The countdown begins! Just one week until the DIA RSIDM Forum 2025, and Red Nucleus is gearing up for an incredible event. ?? We're excited to engage in discussions on: Effective information management strategies Aligning people, processes, and technology Are you attending? Let's connect and explore how we can drive regulatory excellence together! ?? ?? ?? #RSIDM2025 #RedNucleus

Excited to announce that Red Nucleus will be attending the DIA Regulatory Submissions, Information, and Document Management (RSIDM) Forum from February 3-5, 2025! ?? Join us to explore the latest in regulatory information management, data standards, and submission efficiency. Our team is looking forward to connecting with industry leaders and sharing insights on optimizing regulatory processes. See you there! #RegulatoryAffairs #PharmaceuticalIndustry #RedNucleus #RSIDM2025

Emily Ng, MSc, and Mitun Patel, MSc, from the Red Nucleus Market Access and Commercialization team will be presenting a their poster Evaluating Key Drivers for Patient Access and Pricing Trends in ATMPs across Germany, France, and the UK at ISPOR 2024. Don't miss this opportunity to gain crucial insights into the evolving landscape of Advanced Therapy Medicinal Products (ATMPs) in key European markets! Join us at the Poster Session on Monday, November 18, 2024, from 10:30 AM to 1:30 PM to explore the intricate relationship between clinical evidence requirements and HTA outcomes for ATMPs. Don't miss this opportunity to stay ahead in the rapidly evolving field of advanced therapies. Our experts will be available to discuss how these findings can impact your specific projects and challenges in ATMP development and commercialization. Ready to optimize your approach to ATMP market access and pricing strategies? Let's connect at ISPOR 2024 and schedule a meeting to explore how these insights can benefit your organization's pipeline and market access planning. ?? ?? ?? #ISPOR2024 #ATMP #MarketAccess #HealthcareInnovation #Reimbursement